A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
NMDA receptor modulation and severe acute respiratory syndrome treatment
2021
F1000Research
N-Methyl-D-aspartate (NMDA) subtype of glutamate receptors is expressed in the human lungs and central nervous system. NMDA receptor potentiation could increase calcium ion influx and promote downstream signaling mechanisms associated with cellular contractions that are disrupted in severe acute respiratory syndrome. Pharmacological effects generated by triggering glutamate receptor function in the brain, coupled with concurrent stimulation of the respiratory tract, may produce a synergetic
doi:10.12688/f1000research.73897.1
pmid:36544563
pmcid:PMC9745209
fatcat:isflhkkrsvdc5ajqnxh23isjsa